Cytosurge AG

Cytosurge AG Driving the revolution. We provide scientists with FluidFM® to read and analyze life as it unfolds.

CellEDIT delivers vector-free, precise CRISPR engineering, even in hard-to-transfect cells.
👉 https://linktr.ee/cytosurge Cytosurge develops innovative research solutions using its proprietary FluidFM® technology for precise single-cell manipulation thereby fostering advancements in understanding cellular processes such as the ones that drive cancer. With the FluidFM OMNIUM platform, single-cell extracts, or “biopsies” can be taken from living cells, enabling live-sequencing and temporal transcriptomics analysis. Additionally, the CellEDIT Service provides high-quality genetically engineered cell lines through intra-nuclear injections of CRISPR RNPs. Cytosurge's vision is to unlock novel cures by translating next-generation genetic designs into living cells, enabling longer and healthier lives through precision gene engineering. The Company aims to implement advanced genetically engineered cell lines that bring next-generation therapies to fruition, bridging the gap between genetic design tools and manufacturing, and empowering genetic engineers to realize their visionary concepts.

We are further expanding in Europe! 🚀 Following our fantastic collaboration with Altium International Inc. (US & Canada)...
31/03/2026

We are further expanding in Europe! 🚀 Following our fantastic collaboration with Altium International Inc. (US & Canada), we are thrilled to announce that we are expanding our partnership! 🌍 Cytosurge is proud to name Altium Poland as the exclusive distributor of the OMNIUM platform in Poland.

With a team of over 140 experts and a strong foundation in their core values, Trust, Respect, Develop, and Share, Altium is the perfect partner to bring our Same-Cell technology to the Polish scientific community.

Looking to analyze the same living cell over time without destroying it, or push the limits of single-cell manipulation and mechanobiology? Reach out to the Altium team today to discover what FluidFM can do for your lab! 🔬

What an incredible two days! A huge thank you to our global network of partners for making the Cytosurge International D...
27/03/2026

What an incredible two days! A huge thank you to our global network of partners for making the Cytosurge International Distributor Meeting 2026 such a massive success. 🌍🤝

United in Zurich, we lived out our theme: Aligning Strategy. Accelerating Growth. Together, we are more ready than ever to help researchers worldwide break new ground.

A special thank you to our guest speakers, Dr. Orane Guillaume-Gentil (EPFL) and David Nikolaus Hartlmayr (DTU), for showcasing the vast application potential of the FluidFM OMNIUM platform, from minimally invasive live-cell sequencing to advanced single-cell proteomics.

Four years ago, we launched our Service to fix genome engineering's biggest bottleneck: toxic, random delivery and alt...
24/03/2026

Four years ago, we launched our Service to fix genome engineering's biggest bottleneck: toxic, random delivery and altered phenotypes. 🧬🎂
As of today, we've taken the "hard" out of hard-to-transfect.

Using , we mechanically deliver RNPs directly to the nucleus without vectors. In this way, we guarantee a precise dose, drastically reducing off-target effects.
No more probability games or endless clone screening. KI, multiplex, iPSCs... You name it, we edit it. 🎯

Stalled gene-editing project? Connect with our experts! Link in the first comment. 👇

19/03/2026

Discover how we unveil the hidden dynamics of cancer progression. Oone living cell at a time. 🔬
With FluidFM OMNIUM's nanosyringe, we perform gentle, nanometer-precision biopsies to extract tiny portions of cytoplasm, capturing the live transcriptomic state of a single cancer cell without destroying it.
Watch as the exact undergoes epithelial-to-mesenchymal transition ( ). By performing sequential biopsies with FluidFM OMNIUM, we track real-time changes in gene expression across its lifespan, revealing the true molecular shifts that drive cancer invasiveness and treatment resistance.

Stop guessing between snapshots. Start tracking the timeline of the same cell. 🧬Heading to San Diego for ? Our experts are heading to the floor.
📍 Meet the CytoSurge team at Booth 854, and let’s talk temporal transcriptomics.

American Association for Cancer Research

We asked our customers why they chose our Service for their most critical gene-editing projects.Their answers? It wasn...
17/03/2026

We asked our customers why they chose our Service for their most critical gene-editing projects.
Their answers? It wasn't just about the technology; it was about time, trust, and tackling the impossible. 🧬

Swipe through to see how we helped labs across Europe stop troubleshooting and start discovering.
Link to our blog in the first comment 👇

Università degli Studi di Padova

We are hitting the road for a non-stop season of exploring same-cell transcriptomics and proteomics with researchers aro...
12/03/2026

We are hitting the road for a non-stop season of exploring same-cell transcriptomics and proteomics with researchers around the world.
Looking forward to networking, sharing ideas, and seeing the innovation that happens on the spot when our team connects with scientists face-to-face. Whether it’s discussing new applications for FluidFM or diving deep into Live-seq workflow, we can’t wait to see you there.

📍 Where to find us 👇

📩 Register for our newsletter to keep up with our full schedule and see where we are heading next: https://bit.ly/4rLIEYs

We are thrilled to announce our expansion into Australia with Scientex PL!For over 30 years, Scientex has lived by its m...
09/03/2026

We are thrilled to announce our expansion into Australia with Scientex PL!
For over 30 years, Scientex has lived by its motto: Marketing » Science » Experience™, connecting scientists with advanced technologies through deep technical knowledge.
Scientex is now the exclusive distributor for Australian researchers adopting the FluidFM OMNIUM platform. With their strong presence in leading institutions, we know the local scientific community is in excellent hands.
Interested in single-cell manipulation? Reach out to the Scientex team or ask about their famous Morning Tea sessions to see how FluidFM can advance your research! ☕🔬

Today, on International Women’s Day, we celebrate the forward-thinking and passion-driven women who are essential to our...
08/03/2026

Today, on International Women’s Day, we celebrate the forward-thinking and passion-driven women who are essential to our mission: redefining what is possible in single-cell biology.

Their expertise and vision help drive the development of our ® technology and Service, pushing the limits of the small in ways that matter.
From enabling complex gene engineering to unlocking same-cell analysis, their work empowers scientists to achieve breakthroughs with unprecedented precision.

05/03/2026

Did you miss our session on Live-cell sequencing (Live-seq) analysis with Lexogen?
Dr. Ludovica Rizzo (Cytosurge) and Dr. Filippo Passardi (Lexogen) demonstrate how to transform transcriptomics from a terminal snapshot into a dynamic, longitudinal tool.

The key lies in the synergy between non-destructive sampling and LUTHOR HD ultra-low-input library prep. This workflow allows researchers to capture transcriptomic data today and observe the cellular response tomorrow, all within the .

Watch the full replay or download the slides! 🎥 Link in the first comment 👇🎞️

03/03/2026

Dr. Marta Popović’s new DNA repair investigation hinged on creating a precise mutant model.🧬
But there was a catch: the cells carried six alleles of the target gene instead of the expected two.
For her lab at the Ruđer Bošković Institute, this wasn't just a hurdle; it was the deciding factor on whether the research could happen at all.
Despite the complexity, delivered. Our team successfully edited 5 of the ~6 alleles (82.3% efficiency), providing the validated model she needed to launch the study.✅

Today, that "impossible" cell line is the foundation of a new research direction.

Read the full story. Link in the first comment 👇

A decade of innovation, now in one definitive review. 🔬We are proud to share that a new Primer on "Fluidic Force Microsc...
19/02/2026

A decade of innovation, now in one definitive review. 🔬

We are proud to share that a new Primer on "Fluidic Force Microscopy" has been published in Nature Reviews Methods Primers.
Authored by the original pioneers, this review establishes as a transformative technology that has empowered ~140 labs worldwide with novel micro- and nanoscale capabilities.

From the Biology we champion at Cytosurge to additive manufacturing and beyond, FluidFM has opened entirely new research avenues.

What will FluidFM enable in the next decade?

• Read the Primer: https://bit.ly/4aJVuix
• And check out the , which highlights the different applications of FluidFM in biological and materials research: https://go.nature.com/46YA0gF

Competitors rejected these projects. We delivered.We recently achieved successful knockouts in a model, a notoriously ...
13/02/2026

Competitors rejected these projects. We delivered.
We recently achieved successful knockouts in a model, a notoriously difficult-to-transfect cell line, in a difficult-to-access genomic region.

Why did we succeed where others walked away?

bypasses the barriers with Direct, Vector-Free Delivery.
• Precise Stoichiometry: We control exactly how much RNP complex enters the cell.
• Gentle Handling: We keep fragile cells alive.

When standard methods fail, CellEDIT delivers.
"You name the edit, we edit it."

Adresse

Sägereistrasse 25
Glattbrugg
8152

Öffnungszeiten

Montag 09:00 - 18:00
Dienstag 09:00 - 18:00
Mittwoch 09:00 - 18:00
Donnerstag 09:00 - 18:00
Freitag 09:00 - 18:00

Telefon

+41445331450

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Cytosurge AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Verknüpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

Founded in 2009, Cytosurge AG successfully develops, manufactures and distributes cutting-edge and unique high-precision nanotechnology instruments as well as robotic systems based on its patented FluidFM® technology.

Whether via the FluidFM ADD-ON, a powerful upgrade solution for your AFM, the FluidFM BOT, a fully integrated system for cell research, or via the award-winning FluidFM µ3Dprinter for 3D metal printing at the micrometre scale, Cytosurge provides leading-edge tools and processes to those who need or want to go beyond current technological boundaries.

FluidFM – GO BEYOND.